[HTML][HTML] Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors?

G Natale, E Fini, PF Calabrò, M Carli, M Scarselli… - Cancer Letters, 2023 - Elsevier
Beyond its use as an antiepileptic drug, over time valproate has been increasingly used for
several other therapeutic applications. Among these, the antineoplastic effects of valproate …

Current trends and future prospects of drug repositioning in gastrointestinal oncology

N Fatemi, M Karimpour, H Bahrami, MR Zali… - Frontiers in …, 2024 - frontiersin.org
Gastrointestinal (GI) cancers comprise a significant number of cancer cases worldwide and
contribute to a high percentage of cancer-related deaths. To improve survival rates of GI …

Additive Cytotoxic and Colony-Formation Inhibitory Effects of Aspirin and Metformin on PI3KCA-Mutant Colorectal Cancer Cells

J Gonçalves, S Pinto, F Carmo, C Silva… - International Journal of …, 2024 - mdpi.com
Human malignancies are one of the major health-related issues throughout the world and
are anticipated to rise in the future. Despite huge investments made in anticancer drug …

[HTML][HTML] Efficacy and safety of Shenbai Granules for recurrent colorectal adenoma: A multicenter randomized controlled trial

M Ni, Y Zhang, Z Sun, Q Zhou, J Xiao, B Zhang, J Lin… - Phytomedicine, 2024 - Elsevier
Background Colorectal adenoma is benign glandular tumor of colon, the precursor of
colorectal cancer. But no pharmaceutical medication is currently available to treat and …

In Vivo Metabolite Profiling of DMU-212 in ApcMin/+ Mice Using UHPLC-Q/Orbitrap/LTQ MS

J Li, X Li, X Zhou, L Yang, H Sun, L Kong, G Yan… - Molecules, 2023 - mdpi.com
3, 4, 5, 4'-Trans-tetramethoxystilbene (Synonyms: DMU-212) is a resveratrol analogue with
stronger antiproliferative activity and more bioavailability. However, the metabolite …

Five plus Three for the Pancreas

JM Löhr, K Pantel - Clinical Cancer Research, 2023 - AACR
Preneoplastic high-risk lesions in the pancreas need to be differentiated from low-risk
lesions warranting surveillance and eventually surgical intervention. Imaging is used so far; …

Eflornithine for chemoprevention in the high-risk population of colorectal cancer: a systematic review and meta-analysis with trial sequential analysis

L Yang, Y Wang, S Hu, X Wang - Frontiers in Oncology, 2023 - frontiersin.org
Objectives To evaluate the efficacy of Difluoromethylornithine (DFMO) chemoprevention in
the high-risk population for colorectal cancer (CRC). Methods Meta-analysis was conducted …

Preventive effects of chemical drugs on recurrence of colorectal adenomas: systematic review and Bayesian network meta-analysis

S Tan, Y Ou, Y Yang, S Huang, S Chen… - European Journal of …, 2024 - journals.lww.com
Background The onset of colorectal adenomas (CRAs) is significantly associated with
colorectal cancer. The preventive effects of chemical drugs on the recurrence of CRAs have …

基于多胺代谢的药物联合疗法在癌症治疗中的应用.

焦宇彤, 刘森 - Chinese Journal of Biochemistry & Molecular …, 2024 - search.ebscohost.com
摘要多胺是一类普遍存在于生物体中的聚阳离子, 对生命活动发挥至关重要的作用. 在肿瘤中,
多胺稳态通常失调. 肿瘤的发生和发展过程都需要高水平的多胺, 因此, 多胺代谢是癌症治疗的 …

Is Metformin Associated with a Lower Prevalence of Polyps, Adenomas, and Colorectal Carcinoma in Patients with Diabetes Mellitus?

MI Canha, G Ramos, R Prata, P Lages Martins… - Journal of …, 2024 - Springer
Purpose Recent studies suggested a protective role of metformin in the development of
colorectal cancer (CRC) and its precursors. We aimed to investigate if metformin was …